Mukherjee, Samudra
May 2007
Thorax;May2007, Vol. 62 Issue 5, p402
Academic Journal
The article summarizes the study "GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis (PAP)," by K. Uchida and colleagues, featured in a 2007 issue of the "New England Journal of Medicine." The article says that PAP is a rare disorder of excessive accumulation of surfactant components in alveoli. Uchida and colleagues focused on the effect of granulocyte-macrophage colony-surfactant autoantibodies on neutrophils.


Related Articles

  • GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis. Uchida, Kanji; Beck, David C.; Yamamoto, Takashi; Berclaz, Pierre-Yves; Abe, Shuichi; Staudt, Margaret K.; Carey, Brenna C.; Filippi, Marie-Dominique; Wert, Susan E.; Denson, Lee A.; Puchalski, Jonathan T.; Hauck, Diane M.; Trapnell, Bruce C. // New England Journal of Medicine;2/8/2007, Vol. 356 Issue 6, p567 

    Background: Increased mortality from infection in patients with pulmonary alveolar proteinosis occurs in association with high levels of autoantibodies against granulocyte–macrophage colony-stimulating factor (GM-CSF). We tested the hypothesis that neutrophil functions are impaired in...

  • GM-CSF and proteinosis. Khanjari, F.; Watier, H.; Domenech, J.; Asquier, E.; Diot, P.; Nakata, K. // Thorax;Jul2003, Vol. 58 Issue 7, p645 

    Reports on the use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in the treatment of pulmonary alveolar proteinosis (PAP) in patient with no GM-CSF antibodies. Role of GM-CSF production defect in the pathogenesis of PAP.

  • Effects of granulocyte-macrophage colony-stimulating factor and cyclic AMP interaction on human neutrophil apoptosis. Tortorella, Cosimo; Piazzolla, Giuseppina; Spaccavento, Felice; Antonaci, Salvatore // Mediators of Inflammation;Dec98, Vol. 7 Issue 6, p391 

    THE current study was undertaken to evaluate the effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and cyclic AMP (cAMP) signaling interaction on human neutrophil apoptosis, either occurring spontaneously or induced by Fas antigen activation. Results show that GM-CSF,...

  • Granulocyte Colony-stimulating Factor as the Expecting Sword for the Treatment of Severe Sepsis. Murata, Atsuo // Current Pharmaceutical Design;May2003, Vol. 9 Issue 14, p1115 

    Granulocyte colony-stimulating factor is a potent stimulator for neutrophils in the circulation as well as those progenitors to be increased and be grown in the bone marrow. Recombinant forms of this colony-stimulating factor, therefore, are widely using in the various kinds of clinical fields...

  • Treatment of neutropenia in a renal transplant recipient with granulocyte colony-stimulating factor. Moghal, Nadeem E.; Milford, David V.; Darbyshire, P. // Pediatric Nephrology;1998, Vol. 12 Issue 1, p14 

    We report the use of granulocyte colony-stimulating factor (G-CSF) in a renal transplant recipient in whom neutropenia developed following a presumed viral infection. G-CSF was successful in producing a rise in neutrophil count which coincided with a resolution of fever; there was no adverse...

  • The Granulocyte Colony-Stimulating Factor Response after Intrapulmonary and Systemic Bacterial Challenges. Quinton, Lee J.; Nelson, Steve; Boé, Darren M.; Ping Zhang; Qiu Zhong; Kolls, Jay K.; Bagby, Gregory J. // Journal of Infectious Diseases;5/15/2002, Vol. 185 Issue 10, p1476 

    Examines the occurrence of lung-derived granulocyte colony-stimulating factor in the systemic circulation. Increase in the extrapulmonary tissues; Elimination of bacterial pathogens from the lung; Differentiation of bone marrow precursor cells into mature neutrophils.

  • Hematology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS30 

    Presents an abstract of the research manuscript `The in vitro antiinflammatory effects of soluble human GM-CSF receptor (SOLGMR) is demonstrated by downregulation of superoxide anion production by human neutrophils,' by P. Beaudry, C. Pihl et al from the University of Calgary. ...

  • Primary pulmonary alveolar proteinosis. �arac, Sanja; Milic, Rade; Zolotarevski, Lidija; Acimovic, Slobodan; Tomic, Ilija; Plavec, Goran // Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journ;Nov2012, Vol. 69 Issue 11, p1005 

    Introduction. Pulmonary alveolar proteinosis is an uncommon disease characterized by the accumulation of surfactant proteins and phospholipids within the alveolar spaces. Acquired disease can be idiopathic (primary) and secondary. The prevalence of acquired pulmonary alveolar proteinosis is...

  • Increased frequency of GM-CSF secreting PBMC in patients with active systemic lupus erythematosus can be reduced by immunoadsorption. Willeke, P.; Schlüter, B.; Schotte, H.; Erren, M.; Mickholz, E.; Domschke, W.; Gaubitz, M. // Lupus;2004, Vol. 13 Issue 4, p257 

    An objective was to determine the frequency of GM-CSF secreting peripheral blood mononuclear cells (PBMC) in patients with active systemic lupus erythematosus (SLE) and their relation to other cytokine secreting PBMC, activation markers on lymphocytes/monocytes, clinical manifestations and...


Read the Article


Sign out of this library

Other Topics